Advair Diskus News

FDA declines Glaxo on higher Advair dose - Reuters

The 250/50 Advair Diskus was approved in 2003 for maintenance treatment of airflow obstruction in COPD patients. The FDA questioned how Advair 500/50 ...

http://www.reuters.com/article/he... | Posted: Wed Aug 08 09:17:42 -0400 2007

FDA Rejects New Dose for Advair - Forbes

... government regulators rejected the company's request to allow a higher dose of its drug Advair Diskus for patients with a common respiratory disease. ...

http://www.forbes.com/feeds/ap/20... | Posted: Wed Aug 08 09:37:07 -0400 2007

FDA Rejects New Use of Advair - Forbes

AP 08.08.07, 12:06 PM ET Drug maker GlaxoSmithKline PLC said Wednesday government regulators rejected the company's request to allow its Advair Diskus drug ...

http://www.forbes.com/feeds/ap/20... | Posted: Wed Aug 08 09:17:56 -0400 2007

GSK says FDA declines to approve higher dose Advair - Reuters

L: Quote, Profile, Research) said on Wednesday that US health regulators declined to approve a higher strength version of its inhaled Advair Diskus for the ...

http://www.reuters.com/article/go... | Posted: Wed Aug 08 08:25:42 -0400 2007

GSK Receives Decision From FDA on Advair(R) 500/50 for COPD - CNNMoney.com

Advair Diskus may increase this risk, therefore, bone mineral density assessment is recommended prior to starting Advair Diskus and periodically thereafter. ...

http://money.cnn.com/news/newsfee... | Posted: Wed Aug 08 08:06:23 -0400 2007

Choked Out? - Glaxosmithkline's Asthma Drug Advair Diskus 500/50 ... - RTT News

8/8/2007 1:38:13 PM British drug giant Glaxosmithkline plc's (GSK) hopes to expand the label for Advair Diskus appears to be a long shot at least for now ...

http://www.rttnews.com/sp/breakin... | Posted: Wed Aug 08 10:42:24 -0400 2007

Glaxo's Advair Diskus Inhaler Fails to Win Wider Use in US - Bloomberg

8 (Bloomberg) -- GlaxoSmithKline Plc failed to win US approval to market the strongest dose of the asthma inhaler Advair Diskus, the company's top-selling ...

http://www.bloomberg.com/apps/new... | Posted: Wed Aug 08 08:24:19 -0400 2007

GlaxoSmithKline's 500/50 strength of Advair Diskus in COPD not ... - Forbes

... a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation ...

http://www.forbes.com/markets/fee... | Posted: Wed Aug 08 08:27:21 -0400 2007

MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of ... - Earthtimes.org

... Respiratory Inflammatory Disease development programs, as well as contributing to both Advair Diskus and Advair HFA New Drug Application submissions. ...

Posted: Fri Aug 10 04:06:47 -0400 2007